中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | diphenyl (benzyloxycarbonylamino)(phenyl)methylphosphonate | 125882-56-6 | C27H24NO5P | 473.465 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | diphenyl (isothiocyanato(phenyl)methyl)phosphonate | 1403781-79-2 | C20H16NO3PS | 381.392 |
—— | (Formylamino-phenyl-methyl)-phosphonic acid diphenyl ester | 901773-70-4 | C20H18NO4P | 367.341 |
—— | (Isocyanato-phenyl-methyl)-phosphonic acid diphenyl ester | 254982-95-1 | C20H16NO4P | 365.325 |
—— | {[3-(4,6-Dimethyl-pyrimidin-2-yl)-ureido]-phenyl-methyl}-phosphonic acid diphenyl ester | —— | C26H25N4O4P | 488.483 |
—— | 1-[Benzoyl(tert-butyl)amino]-3-[diphenoxyphosphoryl(phenyl)methyl]urea | —— | C31H32N3O5P | 557.586 |
Enzyme specific inhibitors can be designed based on endogenous substrate peptide motifs and modified to yield specific activity-based probes (ABPs). The development/validation of a theranostic ABP-inhibitor prototype for KLK7 protease is presented.